VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators
In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Sehn interviews authors Drs. David-Alexandre Trégouët and Johannes Schetelig on their research published in volume 146 issue 19 of Blood journal. Dr. Trégouët's study conducted a genome-wide association study s…
CAR-iNKT cell immunotherapy and Jagged2/Notch regulation of HSC
In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Anastasios Karadimitris and Maria Carolina Florian on their papers published in Volume 147 Issue 2 of Blood. Dr. Karadimitris' paper "Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal h…
VTE Risk Model in Children and a Novel Tri-specific T-cell-engager for MM
In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Julie Jaffray and Ulrike Philippar on their latest articles published in Blood. Dr. Jaffray discusses her CME article, "Multisite validation of a venous thrombosis risk model in critically ill children through the CHAT Con…
Real-world availability of CAR T-cell therapies
In this week's episode, Blood podcast editor Laurie Sehn interviews Drs. Edward Cliff on his latest research published in volume 147 issue 14 of Blood. Dr. Cliff discusses "Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 count…
Pathophysiology of ANKRD26-related thrombocytopenia and B-ALL recurrence after blinatumomab
In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Shengwen Calvin Li and Hrishi Krishna Srinagesh on their latest articles published in Blood. Dr. Li discusses "Single-cell profiling of ANKRD26 thrombocytopenia reveals progenitor expansion and polyploid apoptosis via JUNB-p21". T…
IBD augmentation of CHIP and Platelet mTOR's impact on Cerebral Malaria
In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Reuben Kapur and Robert Campbell on their latest articles published in Blood. This episode highlights two groundbreaking studies exploring how inflammation drives serious blood and immune-related diseases. In the first interview, …
Orca-T for GVHD–free survival and Understanding VEXAS anemia
In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Everett Meyer and Olivier Hermine on their latest articles published in volume 147 issue 11 of Blood. Dr. Everett Meyer discusses "Orca-T vs allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomiz…
Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM
In this week's episode, Blood editor Laurie Sehn interviews Drs. Efstathios Kastritis and Lucia Chen on their latest articles published in Blood. Dr. Kastritis shares insights and results from the final survival analysis of the ANDROMEDA trial, which determined that adding daratumumab to cyclophosp…
Predictive Markers of Glofitamab Resistance in R/R B-NHL
In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Camille Laurent and Christine Bezombeson on their latest article published in Blood titled "Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL." By using patient-deri…
Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome
In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Mariateresa Fulciniti and Angelo D'Alessandro on their latest articles published in Blood. Dr. Fulciniti, of the Dana Farber Cancer Institute, discusses the development of "PKMYT1 is a targetable vulnerability in del(17p) high-ris…
PODCAST-HAKUKONEET
Voit käyttää verkkosivustoamme etsiäksesi3,821,009-podcasteja ja195,286,681-jaksoja ihmisten, paikkojen tai aiheiden mukaan.
Tietoon sijoittaminen tuottaa parhaiten, joten kuuntelen podcasteja.
‐ Benjamin "Llamacorn" Franklin
MUOKKAA
Kiitos, kun autoit pitämään podcast-tietokantaa ajan tasalla.
